A pilot trial of recombinant interleukin-12 in patients with chronic hepatitis C who previously failed treatment with interferon-α

American Journal of Gastroenterology

Volumn 96, Issue 8, 2001, Pages 2473-2479

  O’Brien, Christopher B ^a,b   Moonka, Dilip K ^a,b   Henzel, Barbara S ^a,b   Caufield, Maureen ^a,b   DeBruin, Michael F ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WYETH AYERST RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; RECOMBINANT INTERLEUKIN 12; VIRUS RNA;

ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEPATITIS C; HUMAN; IMMUNOMODULATION; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; RNA ANALYSIS; TREATMENT FAILURE;

ADJUVANTS, IMMUNOLOGIC; ANALYSIS OF VARIANCE; ANTIVIRAL AGENTS; CYTOKINES; DOUBLE-BLIND METHOD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; INTERLEUKIN-12; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PILOT PROJECTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0034892878     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(01)02520-5     Document Type: Article

References (32)

1. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
2. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells
3. Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor)
4. Natural killer (NK) cell stimulatory factor or IL-12 has differential effects on the proliferation of TCR-alpha beta+, TCR-gamma delta+ T Lymphocytes, and NK cells
5. IL-12 augments antigen-dependent proliferation of activated T lymphocytes
6. Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF). Cytolytic activity and proliferation of NK cells are differentially regulated by NKSF
7. A comparative study of IL-12 (cytotoxic lymphocyte maturation factor)-, IL-2- and IL-7 induced effects on immunomagnetically purified CD56+ NK cells
8. Regulation of human cytolytic lymphocyte responses by interleukin 12
9. IL-12: Initiation cytokine for cell-mediated immunity
10. Interleukin-12 exhibits potent antiviral activity in experimental herpes virus infections
11. Characterization of early IL-12, IFN-alpha, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection
12. Effect of recombinant murine interleukin 12 on influenza pneumonia in a murine model
13. Profiles of cytokines produced by CD4-positive T lymphocytes stimulated by anti-CD3 antibody in patients with chronic hepatitis C
14. MRNA cytokine profile in peripheral blood cells from chronic hepatitis C virus (HCV)-infected patients: Effects of interferon-alpha (IFN-alpha) treatment
15. Human non-germinal center B cell interleukin (IL)-12 production is primarily regulated by T cell signals CD40 ligand, interferon gamma, and IL-10: Role of B cells in the maintenance of T cell responses
16. Interleukin 12 enhances deficient HCV-antigen-induced Th1-type immune response of peripheral blood mononuclear cells
17. Preclinical evaluation of amplicor hepatitis C virus test for detection of hepatitis C virus RNA
18. cDNA sequencing of the 5′ non-coding region (5′ NCR) to determine hepatitis C genotypes in patients with chronic hepatitis C
19. A phase I/II study of recombinant interleukin-12 in patients with chronic hepatitis C
20. Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies
21. Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production
22. Hepatitis C viral dynamics in vivo, and the antiviral efficacy of interferon-alpha therapy
23. Dynamics of hepatitis C viremia following interferon-alpha administration
24. Immunoregulatory cytokines in chronic hepatitis C virus infection: Pre and posttreatment with interferon alfa
25. Intrahepatic expression of pro-inflammatory cytokine mRNAs and interferon efficacy in chronic hepatitis C
26. The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses
27. Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fg12 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response
28. The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses
29. Circulating Th1 and Th2 cytokines in patients with hepatitis C virus infection
30. Serum interleukin 4 and interleukin 10 levels in patients with chronic hepatitis C virus infection
31. High levels of serum interleukin-10 are associated with a poor response to interferon treatment in patients with chronic hepatitis C
32. Detection of type 2-like T-helper cells in hepatitis C virus infection: Implications for hepatitis C virus chronicity